Neurological Biomarker Market Scope And Analysis

  • Report Code : TIPRE00003515
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Neurological Biomarkers Market Trends and Scope by 2031

Buy Now

Neurological Biomarkers Market Report Neurological Biomarkers Market Size and Share Neurological Biomarkers Market Scope and Analysis

Neurological Biomarkers Market Report Scope

Report Attribute Details
Market size in 2021 US$ 5400.90 Million
Market Size by 2031 US$ 18600.93 Million
Global CAGR (2023 - 2031) 13.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Proteomics Biomarker
  • Genomics Biomarker
  • Metabolomics Biomarker
  • Imaging Biomarker
By Application
  • Alzheimer's Disease
  • Parkinson's Disease
  • Schizophrenia
  • Huntington's Disease
  • Spinal Muscular Atrophy
By End User
  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostics
  • Research Organizations
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Abbott
  • Myriad Genetics Inc
  • Bio Rad Laboratories Inc
  • Qiagen
  • Banyan Biomarkers Inc
  • Immunarray Pvt Ltd
  • Quest Diagnostics Incorporated
  • PerkinElmer Inc
  • Merck Millipore
    		•